Glaukos - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsGlaukos

Glaukos

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Photrexa viscous in dextran	Riboflavin 5'-phosphate	2016-04-15		Chronic kidney failure , Cardiovascular diseases , Hypercholesterolemia , Psoriasis , Lung neoplasms , Crohn disease , Skin neoplasms , Familial hypophosphatemic rickets , Osteoporosis , Hypertriglyceridemia , Peripheral vascular diseases , Dermatitis , Alcoholic neuropathy , Common cold , Seizures , Vitamin a deficiency , Hypoparathyroidism , Inborn errors metabolism , Photosensitivity disorders , Methemoglobinemia , Thiamine deficiency , Folic acid deficiency , Vitamin b 6 deficiency , Megaloblastic anemia , Vitamin b deficiency , Xerophthalmia , Penetrating wounds , Tyrosinemias , Wernicke encephalopathy , Beriberi , Scurvy , Night blindness , Riboflavin deficiency , Pellagra , Hypophosphatemia , Rickets

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

open-angle glaucoma

,

ocular hypertension

,

,

,

,

corneal diseases

,

pathologic dilatation

,

,

,

,

Sodium chloride

,

,

,

,

pathologic dilatation

,

corneal diseases

,

open-angle glaucoma

Microcrystalline cellulose

,

pathologic dilatation

,

corneal diseases

,

,

pathologic dilatation

,

corneal diseases

,

,

,

pathologic dilatation

,

corneal diseases

,

,

,

refractive errors

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use